Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
China economic growth slows to rates not seen in more than 3 years, an ominous sign for the clutch of med-tech titans with aggressive strategies in the country.
Abiomed CEO Michael Minogue, along with AdvaMed and other medical device company CEOs launch the MedTech Veteran Program for Returning Heroes, a boot camp for military veterans and wounded warriors.
Hospitals in Denmark resume da Vinci robot-assisted surgeries after a 2-week hiatus spurred by 1 center’s sterilization concerns.
Group purchasing organization Novation reports on recent trends in orthopedic products, finding upward momentum in spinal devices but slowing growth in U.S. joint markets.
The FDA warns that the Onyx liquid embolic system made by Covidien subsidiary ev3 may be linked to 9 patient deaths due to delivery catheters that became stuck in patients’ brains.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
Incoming CEO Mike Mahoney tells an audience at MassDevice’s Big 100 Roundtable East event about the difficult decision to leave a promising career at Johnson & Johnson to – eventually – take the reins at Boston Scientific.